Clinical Trials

30 enrolled

Phase 4 Not yet recruiting

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

NCT07412873 2026-02-17

PROVIDENCE

120 enrolled

Uterine Cervical Neoplasms

NCT07415681 2026-02-17

GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries

116 enrolled

Uterine Cervical Neoplasms

NCT07303751 2026-02-11

RIFT-SSA

80 enrolled

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT07394413 2026-02-06

SHAFT

100 enrolled

Phase 3 Not yet recruiting

Uterine Cervical Neoplasms

NCT07164534 2026-02-04

CHOC-LATE

316 enrolled

Uterine Cervical Neoplasms

NCT07385976 2026-02-04

The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients

100 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT07382505 2026-02-02

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

600 enrolled

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Neoplasm, Residual

NCT07368985 2026-01-27

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

87 enrolled

Adenocarcinoma, Uterine Cervical Neoplasms

NCT07363330 2026-01-26

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

32 enrolled

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence

NCT07362147 2026-01-23

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

74 enrolled

Phase 4 Not yet recruiting

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases, Vaginal Neoplasms, Endometrial Neoplasms

NCT06786429 2026-01-21

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

1,800 enrolled

GastrointestinalGynecologic

Anxiety Disorders, Uterine Cervical Neoplasms, Depression, Hepatitis B, Carcinoma, Hepatocellular, Gallstones

NCT07351110 2026-01-20

PINPOINT

20 enrolled

GynecologicOther

Uterine Cervical Neoplasms, Diabetes Mellitus, Obesity, Overweight

NCT07345897 2026-01-16

Emergency Department-based Cervical Cancer Screening Through Self-sampling

200 enrolled

Uterine Cervical Neoplasms

NCT07348861 2026-01-16

A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer

25 enrolled

Uterine Cervical Neoplasms

NCT07318701 2026-01-06

Multi-agent LLMs for Decision Support in Cervical Cancer During Pregnancy

150 enrolled

Uterine Cervical Neoplasms

NCT07296159 2025-12-22

MySHARE+

130 enrolled

Uterine Cervical Neoplasms

NCT06810739 2025-12-17

PROMETA

8,445 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

NCT07267780 2025-12-05

Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.

130 enrolled

Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT07256977 2025-12-02

SOLUTION2

494 enrolled

Uterine Cervical Neoplasms, Pain, Postoperative

NCT07249021 2025-11-25

IMPACT

1,200 enrolled

Uterine Cervical Neoplasms

NCT07244965 2025-11-24

Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer

42 enrolled

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms

NCT07245381 2025-11-24

Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation

65 enrolled

Uterine Cervical Neoplasms

NCT07240753 2025-11-21

CN-CLCNEC

200 enrolled

Phase 3 Not yet recruiting

Uterine Cervical Neoplasms

NCT07230626 2025-11-17

SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

412 enrolled

Uterine Cervical Neoplasms

NCT07226037 2025-11-10

DOSE-CC

80,000 enrolled

Uterine Cervical Neoplasms

NCT04266275 2025-10-29

Topical Curcumin for HPV Related Cervical Disease

200 enrolled

Uterine Cervical Neoplasms, Communicable Diseases, Neoplasms

NCT07214506 2025-10-29

HOPE

100 enrolled

Uterine Cervical Neoplasms

NCT07204535 2025-10-02

TRUST-GB

80 enrolled

Uterine Cervical Neoplasms, Stress Disorders, Post-Traumatic

NCT07090174 2025-10-01

Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

GastrointestinalGynecologic

27 enrolled

Acquired Immunodeficiency Syndrome, Anus Neoplasms, Uterine Cervical Neoplasms

NCT07088731 2025-09-22

Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

180 enrolled

Uterine Cervical Neoplasms

NCT07175584 2025-09-22

ACS-RT

300 enrolled

Uterine Cervical Neoplasms

NCT07186868 2025-09-22

QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer

25 enrolled

Uterine Cervical Neoplasms

NCT06182241 2025-09-19

Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

80 enrolled

Phase 2/3 Not yet recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

NCT07177716 2025-09-17

Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer

120 enrolled

Uterine Cervical Neoplasms

NCT07172217 2025-09-15

The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC

33 enrolled